evaluate the pharmaceuticals company zepbound on glp-1 and insurance providers Is a GLP-1? Zepbound Lawsuit [2026 Update] |

Parkinsons disease, characterized by dopaminergic neuronal loss in the substantia nigra leading to motor and non-motor symptoms, has also been linked to insulin resistance and impaired cerebral insulin signaling

Drug Target 30 , 244258 (2022)

Literature Search Methodology To conduct the literature review, major scientific databases such as PubMed, Scopus, and Web of Science were searched using appropriately selected keywords and specific search criteria, such as (can-nabinoids OR phytocannabinoids OR cannabinoid OR phytocannabinoid OR THC OR CBD OR CBN OR CBC OR CBG OR THCA OR CBDA OR CBGA OR tetrahydrocanna-binol OR cannabidiol OR cannabinol OR cannabichromene OR cannabigerol OR tetrahy-drocannabinolic acid OR cannabidiolic acid OR cannabigerolic acid) AND ((gastrointestinal OR GI OR GIT OR intestinal OR gut OR gastric) AND (motility OR passage OR paresis OR stasis OR peristalsis OR propulsion OR contractility) OR (permeability OR TEER OR barrier OR FD4))

N., Bell, J